The discovery of potent cRaf1 kinase inhibitors
LACKEY, K, CORY, M, RUTKOWSKE, R. D, VEAL, J. M, WOOD, E. R, DAVIS, R, FRYE, S. V, HARRIS, P. A, HUNTER, R. N, JUNG, D. K, MCDONALD, O. B, MCNUTT, R. W, PEEL, M. R
Published in Bioorganic & medicinal chemistry letters (07.02.2000)
Published in Bioorganic & medicinal chemistry letters (07.02.2000)
Get full text
Journal Article
6-AZASTEROIDS - POTENT DUAL INHIBITORS OF HUMAN TYPE-1 AND 2 STEROID 5-ALPHA-REDUCTASE
FRYE, SV, HAFFNER, CD, MALONEY, PR, MOOK, RA, HINER, RN, BATCHELOR, KW, BRAMSON, HN, STUART, JD, SCHWEIKER, SL, VANARNOLD, J, BICKETT, DM, MOSS, ML, TIAN, GC, UNWALLA, RJ, LEE, FW, TIPPIN, TK, JAMES, MK, GRIZZLE, MK, LONG, JE, SCHUSTER, SV, DORSEY, GF
Published in Journal of medicinal chemistry (24.12.1993)
Published in Journal of medicinal chemistry (24.12.1993)
Get full text
Journal Article
Asymmetric synthesis and Cram’s (chelate) rule
Eliel, E. L., Frye, S. V., Hortelano, E. R., Chen, Xiangning, Bai, Xu
Published in Pure and applied chemistry (01.01.1991)
Published in Pure and applied chemistry (01.01.1991)
Get full text
Journal Article
A prodrug approach to the design of cRaf1 kinase inhibitors with improved cellular activity
Wood, E, Crosby, R M, Dickerson, S, Frye, S V, Griffin, R, Hunter, R, Jung, D K, McDonald, O B, McNutt, R, Mahony, W B, Peel, M R, Ray, J, Lackey, K
Published in Anti-cancer drug design (01.02.2001)
Get more information
Published in Anti-cancer drug design (01.02.2001)
Journal Article
Unique Preclinical Characteristics of GG745, A Potent Dual Inhibitor of 5AR
Bramson, H N, Hermann, D, Batchelor, K W, Lee, F W, James, M K, Frye, S V
Published in The Journal of pharmacology and experimental therapeutics (01.09.1997)
Get full text
Published in The Journal of pharmacology and experimental therapeutics (01.09.1997)
Journal Article
The small‐molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosis
Branchford, B. R., Stalker, T. J., Law, L., Acevedo, G., Sather, S., Brzezinski, C., Wilson, K. M., Minson, K., Lee‐Sherick, A. B., Davizon‐Castillo, P., Ng, C., Zhang, W., Neeves, K. B., Lentz, S. R., Wang, X., Frye, S. V., Shelton Earp, H., DeRyckere, D., Brass, L. F., Graham, D. K., Di Paola, J. A.
Published in Journal of thrombosis and haemostasis (01.02.2018)
Published in Journal of thrombosis and haemostasis (01.02.2018)
Get full text
Journal Article
NT-38 MerTK AS A TARGET IN GLIOBLASTOMA
Wu, J., Huey, L., Bash, R. E., Cohen, S. M., Ewend, M. G., Wang, X., Graham, D. K., Frye, S. V., Earp, H. S., Miller, C. R.
Published in Neuro-oncology (Charlottesville, Va.) (01.11.2014)
Published in Neuro-oncology (Charlottesville, Va.) (01.11.2014)
Get full text
Journal Article
Retraction
Davis, ST, Benson, B G, Framson, H N, Chapman, DE, Dickerson SH, Dold, K M, Eberwein, D J, Edelstein, M, Frye, S V, Gampe RT Jr, Grifffen, R J, Harris, P A, Hassell, A M, Holmes, W D, Hunter, R N, Knick, V B, Lackey, K, Lovejoy, B, Luzzio MJ, Murray, D, Parker, P, Rocque, W J, Shewchuk
Published in Science (American Association for the Advancement of Science) (20.12.2002)
Get full text
Published in Science (American Association for the Advancement of Science) (20.12.2002)
Journal Article
17β-(N-tert-butylcarbamoyl)-4-aza-5α-androstan-1-en-3-one is an active site-directed slow time-dependent inhibitor of human steroid 5α-reductase 1
GAOCHAO TIAN, STUART, J. D, FRYE, S. V, BATCHELOR, K. W, WISEMAN, J. S, MOSS, M. L, DOMANICO, P. L, BRAMSON, H. N, PATEL, I. R, KADWELL, S. H, OVERTON, L. K, KOST, T. A, MOOK, R. A
Published in Biochemistry (Easton) (01.03.1994)
Published in Biochemistry (Easton) (01.03.1994)
Get full text
Journal Article
Inhibition of human steroid 5alpha reductases type I and II by 6-aza-steroids: structural determinants of one-step vs two-step mechanism
Moss, M L, Kuzmic, P, Stuart, J D, Tian, G, Peranteau, A G, Frye, S V, Kadwell, S H, Kost, T A, Overton, L K, Patel, I R
Published in Biochemistry (Easton) (19.03.1996)
Get full text
Published in Biochemistry (Easton) (19.03.1996)
Journal Article
Structure-activity relationships for inhibition of type 1 and 2 human 5 alpha-reductase and human adrenal 3 beta-hydroxy-delta 5-steroid dehydrogenase/3-keto-delta 5-steroid isomerase by 6-azaandrost-4-en-3-ones: optimization of the C17 substituent
Frye, S V, Haffner, C D, Maloney, P R, Hiner, R N, Dorsey, G F, Noe, R A, Unwalla, R J, Batchelor, K W, Bramson, H N, Stuart, J D
Published in Journal of medicinal chemistry (07.07.1995)
Get full text
Published in Journal of medicinal chemistry (07.07.1995)
Journal Article